Eric J. Evans, Alexandre Meyer, Rena M. Conti’s paper “Sizing A Market Entry Reward for the Development of New Antibiotics” M-RCBG Associate Working Paper No. 232, Mossavar-Rahmani Center for Business & Government, Harvard Kennedy School, May 2024.
Matthew Vogel, Rena M. Conti, and Amitabh Chandra’s article “Biopharma Venture Capital And The Inflation Reduction Act”
Health Affairs Forefront, March 5, 2024.
Mark V. Pauly, Debra M. Lederman, and Rena M. Conti’s article “The Inflation Reduction Act Coinsurance Glitch”
Health Affairs Forefront, January 17, 2024.
Rena Conti, TPRI Faculty Director, quoted in NPR, December 28, 2023.
Marta Wosińska and Rena Conti, TPRI Faculty Director, article
“Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot” Brookings Institution, November 1, 2023.
By Chi Heem Wong, Dexin Li, Nina Wang, Jonathan Gruber, Andrew W. Lo & Rena M. Conti
Gene therapy is a new class of medical treatment that alters part of a patient’s genome through the replacement, deletion, or insertion of genetic material.
Rena Conti, Leslie Dach and Richard Frank, Opinion Article The Hill, October 6, 2023.
Rena Conti, TPRI Faculty Director, quoted in The Hill, 09/28/23
Rena Conti, TPRI Faculty Director, quoted in Pharmacy Practice News, 09/19/23
Rena Conti, TPRI Faculty Director, quoted in NPR, July 27, 2023